Sanofi Contingent Value Rights
GCVRZ
GCVRZ was delisted on the 3rd of March, 2020.
136 hedge funds and large institutions have $338M invested in Sanofi Contingent Value Rights in 2013 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 35 reducing their positions, and 17 closing their positions.
4% more capital invested
Capital invested by funds: $324M → $338M (+$13.8M)
7% less funds holding
Funds holding: 146 → 136 (-10)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
40% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 35
59% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
Fir Tree Capital Management
New York
|
+$6.72M |
| 2 |
MCM
Mason Capital Management
New York
|
+$5.99M |
| 3 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
+$2.25M |
| 4 |
DI
Dalton Investments
Las Vegas,
Nevada
|
+$1.24M |
| 5 |
SC
Sophrosyne Capital
New York
|
+$1.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCA
Taconic Capital Advisors
New York
|
-$5.79M |
| 2 |
RCM
Royal Capital Management
New York
|
-$3.55M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$2.51M |
| 4 |
BlackRock
New York
|
-$2.27M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$1.69M |
GCVRZ Hedge Fund Activity: Q3 2013 in Review
136 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q3 2013, worth a combined $338M — up 4.3% from $324M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of GCVRZ and 7 opened new positions — a net loss of 10 holders — while 35 trimmed existing stakes and 21 added.
The largest buyer was Fir Tree Capital Management, adding an estimated $6.72M. The largest seller was Taconic Capital Advisors, exiting entirely with an estimated $5.79M sold.
- 136 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q3 2013, down from 146 in Q2 2013.
- Funds reported $338M of Sanofi Contingent Value Rights stock for Q3 2013, up 4.3% quarter-over-quarter.
- 7 funds opened new Sanofi Contingent Value Rights positions in Q3 2013 and 17 closed out, a net change of -10 holders.
- The largest Sanofi Contingent Value Rights buyer in Q3 2013 was Fir Tree Capital Management, an estimated $6.72M added.
- The largest Sanofi Contingent Value Rights seller in Q3 2013 was Taconic Capital Advisors, an estimated $5.79M sold.
Based on aggregated 13F filings for Q3 2013.